Tus kws kho mob
QP27-26 Update for New-to-Market Medical Drugs: tividenofusp alfa-eknm
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 22, 2026
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 4031 - 4040 ntawm 4374
Tus kws kho mob
DPP-4 Inhibitors and Combinations - Medicaid
Step Therapy, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026
Tus kws kho mob
DPP-4 Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2026
Tus kws kho mob
Topiramate ER - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026
Tus kws kho mob
Vykat XR - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026
Tus kws kho mob
Xdemvy - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026
Tus kws kho mob
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026
Tus kws kho mob
Vtama (tapinarof) - Commercial
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026
Tus kws kho mob
Selective Serotonin Inverse Agonist (SSIA) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2026